Dimensional Fund Advisors
NURO

Dimensional Fund Advisors’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Dimensional Fund Advisors’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,372
Closed -$256K – 3573
2021
Q4 		$256K Sell
6,372
-2,304
-27% -$136K ﹤0.01% 3304
2021
Q3 		$704K Buy
8,676
+2,963
+52% +$265K ﹤0.01% 3117
2021
Q2 		$156K Buy
5,713
+203
+4% +$5.21K ﹤0.01% 3371
2021
Q1 		$150K Buy
+5,510
New +$167K ﹤0.01% 3314

Other funds holding NURO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return
SC
Stephens Consulting Flint, Michigan $309M AUM 14.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors's NURO Position: Q1 2022 in Review

Dimensional Fund Advisors sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q1 2022, closing a stake of 6,372 shares — an estimated $256K sold.

Dimensional Fund Advisors first reported a position in NURO in Q1 2021 and held it in 4 quarters. The position peaked at $704K in Q3 2021. 17 funds tracked by Wall St. Rank hold NURO as of Q1 2022.

  • Dimensional Fund Advisors reported no remaining NeuroMetrix, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 6,372 NeuroMetrix, Inc. Common Stock shares in Q1 2022, an estimated $256K.
  • Dimensional Fund Advisors first reported a position in NeuroMetrix, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • Dimensional Fund Advisors's NeuroMetrix, Inc. Common Stock position peaked at $704K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q1 2022.

Based on Dimensional Fund Advisors's 13F filing for Q1 2022, filed 13 May 2022.